About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 5277 record(s)
Req # A-2018-000605
Copies of documentation submitted for clinical review of the Foquest drug file, including the labelling. The negotiations for approval of the clinical data, including labelling revisions.Organization: Health Canada
January 2020
Req # A-2018-000880
All emails from Cynthia Richardson’s outlook pertaining to Non-personal staffing between September 24, 2017 to October 24, 2017.Organization: Health Canada
January 2020
Req # A-2018-000936
All correspondence between Health Canada and the Quebec Minister of Health and Social Services regarding cannabis legalization from June 1, 2018 to October 15, 2018.Organization: Health Canada
January 2020
Req # A-2018-000939
The Summary Basis of Decision Document and Regulatory Decision Summaries for Hemlibra.Organization: Health Canada
January 2020
Req # A-2018-000950
Any one document that provides the batch number(s) of all REVLIMID used in the comparative studies included in the APO-LENALIDOMIDE abbreviated new drug submission number 218298.Organization: Health Canada
January 2020
Req # A-2019-000934
From January 1st, 2015 to September 10th, 2019, the list of the names of every drug product for which authorization has been requested through the Special Access Programme for drugs.Organization: Health Canada
January 2020
Req # A-2018-001247
All notifiable changes submissions submitted from December 2013 to December 2018 inclusively relating to Eli Lilly Canada Inc’s Cialis products, Drug Identification Number (DINs) 02248088, 02248089, 02296888 and 02296896.Organization: Health Canada
January 2020
Req # A-2018-001511
January 1, 2012 to January 1, 2019: All emails exchanged with client branch staff/contractors and emails exchanged within CSB-IMSD related to “Strategic Regulation Activities Management System, (SRAMS) - IP#343 / PIRT Code: HPFB-DGPSA-15-0004. Assign search to: Arun Sobti , Jason M Chatland, Richard Barrette, Debbie Beresford-Green.Organization: Health Canada
January 2020
Req # A-2018-001513
January 1, 2012 to January 1, 2019: All emails exchanged with client branch staff/contractors and emails exchanged within CSB related to “Strategic Regulation Activities Management System, (SRAMS) - IP#343 / PIRT Code: HPFB-DGPSA-15-0004. Assign search to: Mary Condon, Ian Skinner, Elissa Tilley, Gail Fornarolo, Steven Bednikoff, Marc Charron, Robert Pollock, Dan Sheehy, Ivana MacMillan, Jacques Richer, Scott McKenna.Organization: Health Canada
January 2020
Req # A-2018-001516
January 1, 2012 to January 1, 2019: All information related to “Strategic Regulation Activities Management System, (SRAMS) - IP#343. All emails exchanged. Assign search to: All staff/contractors of the “Department Project Management Office (DPMO). All staff/contractors of the “Investment Management Committees including DG-IP and EC-FIPT.Organization: Health Canada
January 2020